Thanks, Eddie. On Slide 14, let's review our unaudited results for the three months ended March 31, 2024. Our time charter equivalent revenues for Q1 of '24, which we define as revenues net minus voyage related costs and commissions rose to $10.2 million, an increase of 10.2% as we operate a pure product tankers, but benefited from higher spot rates and the addition of the dry bulk carriers. Strong chartering conditions were reflected in our daily TCE for our MRs, which jumped to $31,790 in Q1 of '24. During the quarter, the overall fleet generated TCE of almost $27,600 per vessel through a mix of short-term time and spot charters. Moving to Slide 15. We generated net income to common shareholders of $3.4 million for the three months ended March 31, 2024, or $0.33 basic and $0.30 diluted EPS compared to net income of $8.7 million or $0.81 basic and $0.71 diluted income per share in the same period in 2023. The results from a year ago reflected the sale of our 2009 built MR, which we generated a gain of $8 million. Please note that for accounting purposes, the fully diluted earnings calculation assumes the potential conversion of all the outstanding Series A Convertible Preferred stock into common shares and the elimination of the associated dividend. In Q1 of 2024, the increase in TCE revenues of $900,000 and lower G&A expenses of $600,000 flowed through to adjusted EBITDA, which increased $1.8 million to $6 million. Now flip to Slide 16 to review our capitalization at March 31, 2024. At quarter close, our consolidated leverage ratio of net funded debt stood at 14% of total capitalization. Our weighted average interest rate was 8.2% for the most recent quarter and the next bank loan maturity is scheduled for July of '25. I should point out that at the end of March '24, our total cash reaching -- aggregated $49 million. Most of our excess cash is invested in short-term money market instruments, which currently earn 5.4%. Lastly, as of May 16, 2024, we had repurchased in the open market, 415,000 common shares in total under our initial $2 million buyback program, and there are approximately 10.5 million Pyxis shares currently outstanding. Please note that the planned redemption of 100,000 shares of our preferred stock will avoid potential dilution from conversion into 446,000 common shares. The approved issuance of $1.5 million of restricted stock as part of the Konkar Venture acquisition at an assumed share price of $5.60 would add about 268,000 common shares at closing. Overall, the effect of these two transactions would reduce the fully diluted share count by approximately 1/4 of a million shares at March 31 to 12.1 million fully diluted shares. With that, I'd like to flip the presentation back over to Eddie.